A good skincare routine is the foundation of healthy and glowing skin, but with the thousands of choices available in the market, it can be quite challenging to zero in on products that work effectively. For Australian Therapeutic Goods Administration accredited company Baxter Laboratories, skincare is a science that needs constant enhancements to address specific needs and to deliver benefits that are more than skin-deep.
An innovation partner of major brands such as Clearasil, Banana Boat and Cetaphil, Baxter Laboratories manufactures topical prescription and over-the-counter medicines, skincare and sun care products.
The technologically-driven company invests heavily in research and development and the latest machinery, such as robotics, to offer its clients the best suite of products.
“We see ourselves as a progressive company developing skincare products. We offer innovation and great customer service. We are always reinvesting in our capacity to maintain our hi-tech business,” says director Brent Baxter.
Extending its white label manufacturing scope, Baxter Laboratories also partners with pharmacy chains in Hong Kong, such as Watsons, Guardian and Mannings, and manufactures products under their labels. Baxter Laboratories also supplies generic label products to hospitals in Hong Kong.
With its deep understanding of skincare science, Baxter Laboratories formulates products that are suitable for the specific demographics it serves. As it eyes a greater presence in Asia, the company is focusing on developing formulations that are most suited for Asian skin.
Baxter Laboratories aims to increase its 20 per cent sales from Asia to 50 per cent within three years through partnerships with skincare pharmaceutical companies that are knowledgeable about the Asian market.
“We work with famous brands that customers love. Our business is about enhancing your health and lifestyle and we seek partners who share the same philosophy. We also welcome companies looking to include Australian-quality products in their portfolio,” Baxter says.